Inderdeep Tiwana,

Sr. Regulatory Affairs Specialist, Endoscopy

Boston Scientific Corporation May 21, 2020
100 Boston Scientific Way,
Marlborough, MA 01752

Re: K200483
Trade/Device Name: SpyGlass Discover Digital Catheter, SpyGlass Discover Digital Controller
Regulation Number: 21 CFR 876.1500
Regulation Name: Endoscope and accessories
Regulatory Class: Class II
Product Code: FBN
Dated: February 27, 2020
Received: February 28, 2020

Dear Inderdeep Tiwana:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced
above and have determined the device is substantially equivalent (for the indications for use stated in the
enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the
enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance
with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a
premarket approval application (PMA). You may, therefore, market the device, subject to the general
controls provisions of the Act. Although this letter refers to your product as a device, please be aware that
some cleared products may instead be combination products. The 510(k) Premarket Notification Database
located at [Link] identifies combination
product submissions. The general controls provisions of the Act include requirements for annual registration,
listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We
remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be
subject to additional controls. Existing major regulations affecting your device can be found in the Code of
Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements
concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA
has made a determination that your device complies with other requirements of the Act or any Federal
statutes and regulations administered by other Federal agencies. You must comply with all the Act's
requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part
801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803) for
devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see

U.S. Food & Drug Administration

10903 New Hampshire Avenue Doc ID# 04017.04.15
Silver Spring, MD 20993
[Link]
K200483 - Inderdeep Tiwana Page 2

[Link]
combination-products); good manufacturing practice requirements as set forth in the quality systems (QS)
regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for
combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-
542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part
807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part
803), please go to [Link]
mdr-how-report-medical-device-problems.

For comprehensive regulatory information about medical devices and radiation-emitting products, including
information about labeling regulations, please see Device Advice ([Link]
devices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn
([Link] Additionally, you may contact the
Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See
the DICE website ([Link]
assistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE
by email (DICE@[Link]) or phone (1-800-638-2041 or 301-796-7100).

Sincerely,

Neil R.P. Digitally signed by

Neil R.P. Ogden

Ogden Date: 2020.05.21

[Link] -04'00'
Neil R.P. Ogden, MS
Assistant Director THT4A4
DHT4A: Division of General Surgery Devices
OHT4: Office of Surgical
and Infection Control Devices
Office of Product Evaluation and Quality
Center for Devices and Radiological Health

Enclosure
K200483

7UDGLWLRQDO N 3UHPDUNHW1RWLILFDWLRQ6S\*ODVV'LVFRYHU'LJLWLDO6\VWHP 
3URSULHWDU\DQG&RQILGHQWLDO,QIRUPDWLRQRI%RVWRQ6FLHQWLILF&RUS
 K200483 Page 1 of 4









 N 6XPPDU\IRU6S\*ODVV'LVFRYHU'LJLWDO6\VWHP
6S\*ODVV'LVFRYHU'LJLWDO&DWKHWHUDQG6S\*ODVV'LVFRYHU'LJLWDO&RQWUROOHU 

 6XEPLWWHU

%RVWRQ6FLHQWLILF&RUSRUDWLRQ
(QGRVFRS\'LYLVLRQ
%RVWRQ6FLHQWLILF:D\
0DUOERURXJK0$

&RQWDFW 

3ULPDU\&RQWDFW ,QGHUGHHS7LZDQD
   6U5HJXODWRU\6SHFLDOLVW
   3KRQH  
   (PDLO,QGHUGHHSWLZDQD#EVFLFRP

6HFRQGDU\&RQWDFW $VKOH\6DQWRV
   'LUHFWRU5HJXODWRU\$IIDLUV(QGRVFRS\
   3KRQH  
   (PDLO$VKOH\VDQWRV#EVFLFRP

'DWH3UHSDUHG)HEUXDU\


 'HYLFH

7UDGH1DPH 6S\*ODVV'LVFRYHU'LJLWDO6\VWHP
&RPPRQ1DPH &KROHGRFKRVFRSHDQGDFFHVVRULHVIOH[LEOHULJLG
6XUJLFDOFDPHUDDQGDFFHVVRULHV/('OLJKWVRXUFH
3URGXFW&RGH )%1.40171
'HYLFH&ODVVDQG3DQHO &ODVV,,*DVWURHQWHURORJ\8URORJ\ )%1171 
&ODVV,*HQHUDODQGSODVWLFVXUJHU\ .40 
&ODVVLILFDWLRQ5HJXODWLRQ &)5 )%1171 
&)5 .40 



7UDGLWLRQDO N 3UHPDUNHW1RWLILFDWLRQ6S\*ODVV'LVFRYHU'LJLWLDO6\VWHP
3URSULHWDU\DQG&RQILGHQWLDO,QIRUPDWLRQRI%RVWRQ6FLHQWLILF&RUS
 K200483 Page 2 of 4


 3UHGLFDWH'HYLFHV

&DWKHWHU

7UDGH1DPH 6S\*ODVV'6'LUHFW9LVXDOL]DWLRQ6\VWHP
'HYLFH1DPH 6S\6FRSH'6,,$FFHVVDQG'HOLYHU\&DWKHWHU
0DQXIDFWXUHU %RVWRQ6FLHQWLILF&RUS
&OHDUDQFH1XPEHU .
&RPPRQ1DPH &KROHGRFKRVFRSHDQGDFFHVVRULHVIOH[LEOHULJLG
3URGXFW&RGH )%1171
'HYLFH&ODVVDQG3DQHO &ODVV,,*DVWURHQWHURORJ\8URORJ\ )%1171 
&ODVVLILFDWLRQ5HJXODWLRQ &)5 )%1171 

7UDGH1DPH )OH[LEOH9LGHR8UHWHUR&KROHGRFKRVFRSH6\VWHP
0DQXIDFWXUHU .DUO6WRU]
&OHDUDQFH1XPEHU .
&RPPRQ1DPH &ODVV,,*DVWURHQWHURORJ\8URORJ\ )%1)*% 
3URGXFW&RGH )%1)*%
'HYLFH&ODVVDQG3DQHO &ODVV,,*DVWURHQWHURORJ\8URORJ\
&ODVVLILFDWLRQ5HJXODWLRQ &)5

7UDGH1DPH 85)38UHWHURUHQRILEHUVFRSH&KROHGRVFKRILUEHUVFRSH
0DQXIDFWXUHU 2O\PSXV0HGLFDO6\VWHP&RUS
&OHDUDQFH1XPEHU .
&RPPRQ1DPH &ODVV,,*DVWURHQWHURORJ\8URORJ\ )%1 
3URGXFW&RGH )%1
'HYLFH&ODVVDQG3DQHO &ODVV,,*DVWURHQWHURORJ\8URORJ\
&ODVVLILFDWLRQ5HJXODWLRQ &)5

&RQWUROOHU

7UDGH1DPH 6S\*ODVV'6'LUHFW9LVXDOL]DWLRQ6\VWHP
'HYLFH1DPH 6S\*ODVV'6'LJLWDO&RQWUROOHU
0DQXIDFWXUHU %RVWRQ6FLHQWLILF&RUS
&OHDUDQFH1XPEHU .
&RPPRQ1DPH 6XUJLFDOFDPHUDDQGDFFHVVRULHV/('OLJKWVRXUFH
3URGXFW&RGH .40
'HYLFH&ODVVDQG3DQHO &ODVV,*HQHUDODQGSODVWLFVXUJHU\ .40 
&ODVVLILFDWLRQ5HJXODWLRQ &)5 .40 








7UDGLWLRQDO N 3UHPDUNHW1RWLILFDWLRQ6S\*ODVV'LVFRYHU'LJLWLDO6\VWHP
3URSULHWDU\DQG&RQILGHQWLDO,QIRUPDWLRQRI%RVWRQ6FLHQWLILF&RUS
 K200483 Page 3 of 4


 'HYLFH'HVFULSWLRQ

7KH6S\*ODVV'LVFRYHU'LJLWDO6\VWHPFRPSULVHVWZRFRPSRQHQWV  DVWHULOHVLQJOHXVH
HQGRVFRSHWKH6S\*ODVV'LVFRYHU'LJLWDO&DWKHWHU WKH³&DWKHWHU´ DQG  DQRQVWHULOH
HQGRVFRSLFYLGHRLPDJLQJV\VWHPWKH6S\*ODVV'LVFRYHU'LJLWDO&RQWUROOHU WKH
³&RQWUROOHU´ 

7KH6S\*ODVV'LVFRYHU'LJLWDO&DWKHWHUFRPSULVHVDKDQGOHDQLQVHUWLRQWXEHDQGD
FRQQHFWLRQFDEOH7KHKDQGOHLQFOXGHVWZRDUWLFXODWLRQFRQWURONQREVDOHYHUWRORFNWKH
FRQWURONQREVLQSODFHFRQQHFWRUVIRULUULJDWLRQDQGDVSLUDWLRQDZRUNLQJFKDQQHOSRUW7KH
LQVHUWLRQWXEHFRQWDLQVRQHZRUNLQJFKDQQHOIRUDFFHVVRU\GHYLFHVDQGDVSLUDWLRQWZR
FKDQQHOVIRULUULJDWLRQWZRRSWLFDOILEHUVWRWUDQVPLWLOOXPLQDWLRQIURPWKH&RQWUROOHUDQG
ZLULQJWRWUDQVPLWYLGHRVLJQDOVWRWKH&RQWUROOHU7KHEHQGLQJVHFWLRQDWWKHGLVWDOSRUWLRQRI
WKHLQVHUWLRQWXEHLVFRQWUROOHGE\WKHXVHUYLDWKHDUWLFXODWLRQFRQWURONQREVRQWKHKDQGOH
7KHGLVWDOHQGRIWKHLQVHUWLRQWXEHFRQWDLQVDFDPHUDIRUFDSWXULQJYLGHRDQGWUDQVPLWWLQJLW
WRWKH&RQWUROOHUHOHPHQWVIRUWUDQVPLWWLQJLOOXPLQDWLRQIURPWKH&RQWUROOHUDQGWKHGLVWDO
RSHQLQJVRIWKHLUULJDWLRQDQGZRUNLQJFKDQQHOV7KHFDWKHWHUFDEOHFRQQHFWVWKHFDWKHWHU
KDQGOHWRWKH&RQWUROOHUIRUWUDQVPLWWLQJLOOXPLQDWLRQDQGYLGHRVLJQDOV

7KH&RQWUROOHULVDQHQGRVFRSLFYLGHRLPDJLQJFRPSRQHQWWKDWFRPELQHVWKHIXQFWLRQDOLW\RI
DFDPHUDDQGDQ/('OLJKWVRXUFH7KH&RQWUROOHUUHFHLYHVYLGHRVLJQDOVIURPWKHFDWKHWHU
SURFHVVHVWKHYLGHRVLJQDOVDQGRXWSXWVYLGHRLPDJHVWRDQDWWDFKHGPRQLWRU7KH&RQWUROOHU
DOVRJHQHUDWHVDQGFRQWUROVWKHLOOXPLQDWLRQWUDQVPLWWHGWRWKHGLVWDOHQGRIWKHFDWKHWHU7KH
XVHULQWHUIDFHRIWKH&RQWUROOHUFRPSULVHVDSRZHUEXWWRQDUHFHSWDFOHWRFRQQHFWWKHFDWKHWHU
FRQQHFWLRQFDEOHEXWWRQVWRWXUQLOOXPLQDWLRQRQRURIIDQGWRFRQWUROWKHLOOXPLQDWLRQ
LQWHQVLW\DQGDQLOOXPLQDWLRQLQWHQVLW\LQGLFDWRU7KH&RQWUROOHURXWSXWVYLGHRLPDJHVWRDQ
DWWDFKHGPRQLWRUYLD'9,9*$RU69LGHRSRUWVDQGWKHXVHUPD\VHOHFW176&RU3$/
YLGHRIRUPDWVDFFRUGLQJWRWKHJHRJUDSKLFUHJLRQRIXVH

 ,QGLFDWLRQVIRU8VH

7KH6S\*ODVV'LVFRYHU'LJLWDO6\VWHPLVLQGLFDWHGIRUXVHLQGLDJQRVWLFDQGWKHUDSHXWLF
DSSOLFDWLRQVGXULQJHQGRVFRSLFSURFHGXUHVLQWKHSDQFUHDWLFRELOLDU\V\VWHPLQFOXGLQJWKH
KHSDWLFGXFWV7KH6S\*ODVV'LVFRYHU'LJLWDO6\VWHPFRPSULVHVWZRFRPSRQHQWVWKH
6S\*ODVV'LVFRYHU'LJLWDO&DWKHWHUDQGWKH6S\*ODVV'LVFRYHU'LJLWDO&RQWUROOHU

7KH6S\*ODVV'LVFRYHU'LJLWDO&DWKHWHULVLQWHQGHGWRSURYLGHGLUHFWYLVXDOL]DWLRQDQGWR
JXLGHERWKRSWLFDODQGDFFHVVRU\GHYLFHVIRUGLDJQRVWLFDQGWKHUDSHXWLFDSSOLFDWLRQVGXULQJ
HQGRVFRSLFSURFHGXUHVLQWKHSDQFUHDWLFRELOLDU\V\VWHPLQFOXGLQJWKHKHSDWLFGXFWV

7KH6S\*ODVV'LVFRYHU'LJLWDO&RQWUROOHULVLQWHQGHGWRSURYLGHLOOXPLQDWLRQDQG
UHFHLYHSURFHVVDQGRXWSXWLPDJHVIURPWKH6S\*ODVV'LVFRYHU'LJLWDO&DWKHWHU
IRUGLDJQRVWLFDQGWKHUDSHXWLFDSSOLFDWLRQVGXULQJHQGRVFRSLFSURFHGXUHVLQWKH
SDQFUHDWLFRELOLDU\V\VWHPLQFOXGLQJWKHKHSDWLFGXFWV



7UDGLWLRQDO N 3UHPDUNHW1RWLILFDWLRQ6S\*ODVV'LVFRYHU'LJLWLDO6\VWHP
3URSULHWDU\DQG&RQILGHQWLDO,QIRUPDWLRQRI%RVWRQ6FLHQWLILF&RUS
 K200483 Page 4 of 4


 7HFKQRORJLFDO&KDUDFWHULVWLFV

7KHSURSRVHG6S\*ODVV'LVFRYHU'LJLWDO6\VWHPVKDUHVWKHVDPHLQWHQGHGXVHDQG
IXQGDPHQWDOVFLHQWLILFWHFKQRORJ\DVWKHSUHGLFDWH6S\*ODVV'6'LUHFW9LVXDOL]DWLRQ6\VWHP
. 7KHWZRV\VWHPVVKDUHVDPHLQGLFDWLRQVIRUXVHDQGQHDUO\LGHQWLFDO
WHFKQRORJLFDOFKDUDFWHULVWLFVLQFOXGLQJ&026LPDJHVHQVRUVIRUYLVXDOL]DWLRQOLJKWHPLWWLQJ
GLRGHV /('V IRULOOXPLQDWLRQDQGYLGHRRXWSXWFDSDELOLWLHV0RVWRIWKH6S\*ODVV'LVFRYHU
'LJLWDO&DWKHWHUFRPSRQHQWVDUHLGHQWLFDOLQGLPHQVLRQVDQGLQPHFKDQLFDOSHUIRUPDQFHWR
LWVSUHGLFDWH7KHSULPDU\GHVLJQFKDQJHVLQFRUSRUDWHGLQWKH6S\*ODVV'LVFRYHU'LJLWDO
&DWKHWHUDUH  DVKRUWHUZRUNLQJOHQJWK  PRGLILFDWLRQVWRWKHSXOOH\WRFRPSHQVDWHIRU
WKHVKRUWHUZRUNLQJOHQJWK  ORQJHULUULJDWLRQDQGDVSLUDWLRQWXELQJDQG  UHPRYDORIWKH
VWUDSDQGEUDFNHW%HVLGHVWKHVHFKDQJHVWKHGHVLJQFRPSRQHQWVDQGPDWHULDOVRI6S\*ODVV
'LVFRYHU'LJLWDO&DWKHWHUDUHQHDUO\LGHQWLFDOWRWKH6S\6FRSH'6,,$FFHVVDQG'HOLYHU\
&DWKHWHU . 

 6XEVWDQWLDO(TXLYDOHQFH

7KHSURSRVHG6S\*ODVV'LVFRYHU'LJLWDO&DWKHWHULVVXEVWDQWLDOO\HTXLYDOHQWLQGHVLJQ
IHDWXUHVDQGIXQFWLRQDOLW\WRWKH6S\6FRSH'6,,$FFHVVDQG'HOLYHU\&DWKHWHU,WVIXQFWLRQ
FRQVLVWVRISURYLGLQJGLUHFWYLVXDOL]DWLRQRIWKHSDQFUHDWLFRELOLDU\V\VWHP,WLVDOVRXVHGWR
JXLGHERWKRSWLFDODQGDFFHVVRU\GHYLFHVIRUGLDJQRVWLFDQGWKHUDSHXWLFDSSOLFDWLRQVGXULQJ
HQGRVFRSLFSURFHGXUHVLQWKHSDQFUHDWLFRELOLDU\V\VWHPLQFOXGLQJWKHKHSDWLFGXFWV,W
SURYLGHVLPDJLQJDQGLOOXPLQDWLRQE\PHDQVRID&026VHQVRUDQGSODVWLFRSWLFDOILEHUV
ZD\VWHHUDEOHQDYLJDWLRQLUULJDWLRQDQGDVSLUDWLRQ

7KHSULPDU\GLIIHUHQFHEHWZHHQWKH6S\*ODVV'LVFRYHU'LJLWDO&DWKHWHUDQGWKH6S\6FRSH
'6,,$FFHVVDQG'HOLYHU\&DWKHWHULVLWVFDWKHWHUZRUNLQJOHQJWK8QOLNHWKH6S\6FRSH'6
,,$FFHVVDQG'HOLYHU\&DWKHWHUWKH6S\*ODVV'LVFRYHU'LJLWDO&DWKHWHULVQRWLQWHQGHGWREH
XVHGWKURXJKDGXRGHQRVFRSH7KH6S\*ODVV'LVFRYHU'LJLWDO&DWKHWHULVLQWHQGHGWRDFFHVV
WDUJHWDQDWRP\WKURXJKWKUHHSRVVLEOHPHWKRGV/DSDURVFRSLFDOO\SHUFXWDQHRXVO\DQGRSHQ
VXUJLFDO

7KHVHFRQGDU\SUHGLFDWHGHYLFHVVHOHFWHGIRU6S\*ODVV'LVFRYHU'LJLWDO&DWKHWHUDUH  
)OH[LEOH9LGHR8UHWHUR&KROHGRFKRVFRSH6\VWHP .DUO6WRU] .DQG  85)3
8UHWHURUHQRILEHUVFRSH&KROHGRVFKRILUEHUVFRSH 2O\PSXV .7KHVHWZRFDWKHWHUV
VKDUHVLPLODUZRUNLQJFDWKHWHUOHQJWKDVWKH6S\*ODVV'LVFRYHU'LJLWDO&DWKHWHU+HQFHWKH
DFFHVVLQJPHWKRGWRWKHWDUJHWDQDWRP\LVVLPLODUWRWKHSURSRVHG6S\*ODVV'LVFRYHU'LJLWDO
&DWKHWHU









7UDGLWLRQDO N 3UHPDUNHW1RWLILFDWLRQ6S\*ODVV'LVFRYHU'LJLWLDO6\VWHP
3URSULHWDU\DQG&RQILGHQWLDO,QIRUPDWLRQRI%RVWRQ6FLHQWLILF&RUS